General Catalyst adds 10 new health system partners

2022-11-15
General Catalyst adds 10 new health system partners
Preview
来源: mobihealthnews
Photo: FS Productions/Blend Images/Getty Images
Venture capital firm General Catalyst announced a slew of new health system partners on Tuesday, bringing its total number of collaborators in the U.S. to 14.
The 10 new partners include Banner Health, Cincinnati Children's Hospital Medical Center, Hackensack Meridian Health, Health First, MetroHealth, OhioHealth, the Medical University of South Carolina (MUSC), UC Davis Health, UC Irvine Health and Universal Health Services (UHS).
General Catalyst had previously revealed partnerships with WellSpan Health, Jefferson Health, Intermountain and HCA as well as Guy's and St ThomasNHS Foundation Trust in the UK. The VC aims to work with these health systems to determine areas for innovation, then co-invest in or build health tech companies.
Daryl Tol, General Catalyst's head of health assurance ecosystem, told MobiHealthNews the firm wanted to have a range of providers across the country, including academic medical centers, for-profit health systems and not-for-profit providers.
Tol said the health systems' approach to change also affected General Catalyst's decision.
"Do they have a really engaged and supportive executive team? Is there dissatisfaction with the way things are, and a readiness to shift? Is there good board engagement and strategy around transformation?" he said. "So we looked at both the broader diversity of systems, and we looked at the internal characteristics as well."
THE LARGER TREND
General Catalyst announced its first partnership with HCA in August 2021. Tol said the VC has been piloting partnerships with the early partners. They visit the systems, listen to strategy and concerns, and work on yearly activation plans.
Tol, who formerly held multiple executive roles at AdventHealth in Florida, joined General Catalyst earlier this year. He said the VC has a long-term focus when it comes to these health system partnerships, and they'll consider multiple avenues to innovation, from expanding a tool they already use, to investing in or co-developing a new solution. More partners could be added as well.
"I think we'll add more over time and grow our bandwidth and capability over time," he said. "But I also think it's going to take a little time to refine our approach, to make sure it's working, to measure, to hold ourselves accountable, before we start growing for the sake of growth."
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。